Also categorized in BoardNews:
Germany's Corporate Governance Problem
x hide permanently

Ackman’s $5.3 Billion Allergan Bet Examined Before Vote


Allergan, the maker of the anti-wrinkle treatment botox, seeks a court order barring Ackman from voting the shares held by his PS Fund 1 at a Dec. 18 meeting, where shareholders will be asked to remove six directors who oppose Valeant’s $54 billion unsolicited bid...

Mentions: Management hostile takeover Board of Directors